Similar Articles
1221 Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment
1222 Hepatitis B viral load affects prognosis of hepatocellular carcinoma
1223 Characterization of monocarboxylate transporter activity in hepatocellular carcinoma
1224 Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
1225 Incorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapy
1226 Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
1227 Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis
1228 Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation
1229 Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
1230 Current management of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA